PCR detects bands consistent with the expression of receptors associated with pruritus in canine dorsal root ganglia

Veterinary Dermatology

Volumn 25, Issue 1, 2014, Pages

  Rossbach, Kristine ^a   Bäumer, Wolfgang ^a,b  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

ENDOTHELIN A RECEPTOR; HISTAMINE RECEPTOR; INTERLEUKIN RECEPTOR; NEUROKININ 1 RECEPTOR; OPIATE RECEPTOR; RNA; TOLL LIKE RECEPTOR 7; VANILLOID RECEPTOR;

ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; PRURITUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL GANGLION;

ANIMALS; DOG DISEASES; DOGS; GANGLIA, SPINAL; GENE EXPRESSION REGULATION; PRURITUS; RECEPTOR, ENDOTHELIN A; RECEPTORS, HISTAMINE; RECEPTORS, INTERLEUKIN; RECEPTORS, NEUROKININ-1; RECEPTORS, OPIOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TOLL-LIKE RECEPTOR 7; TRPV CATION CHANNELS;

EID: 84892896514     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/vde.12093     Document Type: Article

References (52)

1. Scott DW, Paradis M. A survey of canine and feline skin disorders seen in a university practice: Small Animal Clinic, University of Montréal, Saint-Hyacinthe, Québec (1987-1988). Can Vet J 1990; 31: 830-835.
2. Steinhoff M, Bienenstock J, Schmelz M et al. Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus. J Invest Dermatol 2006; 126: 1705-1718.
3. Inagaki N, Nagao M, Igeta K et al. Scratching behavior in various strains of mice. Skin Pharmacol Appl Skin Physiol 2001; 14: 87-96.
4. Schmelz M, Schmidt R, Bickel A et al. Specific C-receptors for itch in human skin. J Neurosci 1997; 17: 8003-8008.
5. Carr MN, Torres SM, Koch SN et al. Investigation of the pruritogenic effects of histamine, serotonin, tryptase, substance P and interleukin-2 in healthy dogs. Vet Dermatol 2009; 20: 105-110.
6. Smith ES, Blass GR, Lewin GR et al. Absence of histamine-induced itch in the African naked mole-rat and "rescue" by Substance P. Mol Pain 2010; 6: 29.
7. Thomsen JS, Petersen MB, Benfeldt E et al. Scratch induction in the rat by intradermal serotonin: a model for pruritus. Acta Derm Venereol 2001; 81: 250-254.
8. Hagermark O. Peripheral and central mediators of itch. Skin Pharmacol 1992; 5: 1-8.
9. Kim SJ, Park GH, Kim D et al. Analysis of cellular and behavioral responses to imiquimod reveals a unique itch pathway in transient receptor potential vanilloid 1 (TRPV1)-expressing neurons. Proc Natl Acad Sci USA 2011; 108: 3371-3376.
10. Rossbach K, Stark H, Sander K et al. The histamine H receptor as a new target for treatment of canine inflammatory skin diseases. Vet Dermatol 2009; 20: 555-561.
11. Temizel EM, Cihan H, Akhtardanesh B et al. Effect of prednisolone and cetirizine on D. farinae and histamine-induced wheal and flare response in healthy dogs. Tierarztl Prax Ausg K Kleintiere Heimtiere 2011; 39: 25-30.
12. Tey HL, Yosipovitch G. Targeted treatment of pruritus: a look into the future. Br J Dermatol 2011; 165: 5-17.
13. Yosipovitch G. The pruritus receptor unit: a target for novel therapies. J Invest Dermatol 2007; 127: 1857-1859.
14. Inagaki N, Igeta K, Kim JF et al. Involvement of unique mechanisms in the induction of scratching behavior in BALB/c mice by compound 48/80. Eur J Pharmacol 2002; 448: 175-183.
15. Noli C, Minafo G, Galzerano M et al. Quality of life of dogs with skin diseases and their owners. Part 1: development and validation of a questionnaire. Vet Dermatol 2011; 22: 335-343.
16. Hägermark O, Hökfelt T, Pernow B. Flare and itch induced by substance P in human skin. J Invest Dermatol 1978; 71: 233-235.
17. 1 tachykinin receptors in mice. J Pharmacol Exp Ther 1998; 286: 1140-1145.
18. Andoh T, Nagasawa T, Kuraishi Y. Expression of tachykinin NK1 receptor mRNA in dorsal root ganglia of the mouse. Brain Res Mol Brain Res 1996; 35: 329-332.
19. Bie B, Zhao ZQ. Peripheral inflammation alters desensitization of substance P-evoked current in rat dorsal root ganglion neurons. Eur J Pharmacol 2011; 670: 495-499.
20. 4 receptors are involved in pruritus. Neuroscience 2011; 190: 89-102.
21. Ständer S, Gunzer M, Metze D et al. Localization of μ-opioid receptor 1A on sensory nerve fibers in human skin. Regul Pept 2002; 110: 75-83.
22. Bigliardi PL, Tobin DJ, Gaveriaux-Ruff C et al. Opioids and the skin - where do we stand? Exp Dermatol 2009; 18: 424-430.
23. Bigliardi-Qi M, Bigliardi PL, Eberle AN et al. β-Endorphin stimulates cytokeratin 16 expression and downregulates μ-opiate receptor expression in human epidermis. J Invest Dermatol 2000; 114: 527-532.
24. McQueen DS, Noble MA, Bond SM. Endothelin-1 activates ETA receptors to cause reflex scratching in BALB/c mice. Br J Pharmacol 2007; 151: 278-284.
25. Trentin PG, Fernandes MB, D'Orleans-Juste P et al. Endothelin-1 causes pruritus in mice. Exp Biol Med (Maywood) 2006; 23: 1146-1151.
26. Andoh T, Yoshida T, Lee JB et al. Cathepsin E induces itch-related response through the production of endothelin-1 in mice. Eur J Pharmacol 2012; 686: 16-21.
27. Pomonis JD, Rogers SD, Peters CM et al. Expression and localization of endothelin receptors: implications for the involvement of peripheral glia in nociception. J Neurosci 2001; 21: 999-1006.
28. Liu T, Xu ZZ, Park CK et al. Toll-like receptor 7 mediates pruritus. Nat Neurosci 2010; 13: 1460-1462.
29. Ständer S, Raap U, Weisshaar E et al. Pathogenesis of pruritus. J Dtsch Dermatol Ges 2011; 9: 456-463.
30. Dillon SR, Sprecher C, Hammond A et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 2004; 5: 752-760.
31. Sonkoly E, Muller A, Lauerma AI et al. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 2006; 117: 411-417.
32. Gonzales AJ, Humphrey WR, Messamore JE et al. Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis. Vet Dermatol 2013; 24: 48-53, e11-e12.
33. Bando T, Morikawa Y, Komori T et al. Complete overlap of interleukin-31 receptor A and oncostatin M receptor β in the adult dorsal root ganglia with distinct developmental expression patterns. Neuroscience 2006; 142: 1263-1271.
34. Caterina MJ, Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Annu Rev Neurosci 2001; 24: 487-517.
35. Green BG, Shaffer GS. The sensory response to capsaicin during repeated topical exposures: differential effects on sensations of itching and pungency. Pain 1993; 53: 323-334.
36. Schmelz M, Schmidt R, Weidner C et al. Chemical response pattern of different classes of C-nociceptors to pruritogens and algogens. J Neurophysiol 2003; 89: 2441-2448.
37. 2 and 12-lipoxygenase. J Neurosci 2007; 27: 2331-2337.
38. Shimada SG, LaMotte RH. Behavioral differentiation between itch and pain in mouse. Pain 2008; 139: 681-687.
39. Katugampola R, Church MK, Clough GF. The neurogenic vasodilator response to endothelin-1: a study in human skin in vivo. Exp Physiol 2000; 85: 839-846.
40. Kamei J, Nagase H. Norbinaltorphimine, a selective κ-opioid receptor antagonist, induces an itch-associated response in mice. Eur J Pharmacol 2001; 418: 141-145.
41. Sorge J, Sittl R. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study. Clin Ther 2004; 26: 1808-1820.
42. Umeuchi H, Togashi Y, Honda T et al. Involvement of central μ-opioid system in the scratching behavior in mice, and the suppression of it by the activation of κ-opioid system. Eur J Pharmacol 2003; 477: 29-35.
43. Yamamoto A, Sugimoto Y. Involvement of peripheral mu opioid receptors in scratching behavior in mice. Eur J Pharmacol 2010; 649: 336-341.
44. Gollnick H, Barona CG, Frank RG et al. Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study in Europe. Eur J Dermatol 2005; 15: 374-381.
45. Amatya B, Nordlind K, Wahlgren CF. Responses to intradermal injections of substance P in psoriasis patients with pruritus. Skin Pharmacol Physiol 2010; 23: 133-138.
46. 4 in substance P-induced itch-associated response in mice. J Invest Dermatol 2001; 117: 1621-1626.
47. 3 antagonist-induced scratching behavior in mice. J Pharmacol Sci 2006; 100: 297-302.
48. Ohmura T, Hayashi T, Satoh Y et al. Involvement of substance P in scratching behaviour in an atopic dermatitis model. Eur J Pharmacol 2004; 491: 191-194.
49. Grimstad Ø, Sawanobori Y, Vestergaard C et al. Anti-interleukin-31-antibodies ameliorate scratching behaviour in NC/Nga mice: a model of atopic dermatitis. Exp Dermatol 2009; 18: 35-43.
50. Jinks SL, Carstens E. Responses of superficial dorsal horn neurons to intradermal serotonin and other irritants: comparison with scratching behavior. J Neurophysiol 2002; 87: 1280-1289.
51. Klein A, Carstens MI, Carstens E. Facial injections of pruritogens or algogens elicit distinct behavior responses in rats and excite overlapping populations of primary sensory and trigeminal subnucleus caudalis neurons. J Neurophysiol 2011; 106: 1078-1088.
52. 4 receptor mRNA in the skin and other tissues of normal dogs. Vet Dermatol 2011; 22: 396-400.